ATE404226T1 - Zusammensetzung enthaltend auf festen teilchen immobilisierte radioisotopen, sowie deren verwendung in der brachytherapie - Google Patents
Zusammensetzung enthaltend auf festen teilchen immobilisierte radioisotopen, sowie deren verwendung in der brachytherapieInfo
- Publication number
- ATE404226T1 ATE404226T1 AT98830776T AT98830776T ATE404226T1 AT E404226 T1 ATE404226 T1 AT E404226T1 AT 98830776 T AT98830776 T AT 98830776T AT 98830776 T AT98830776 T AT 98830776T AT E404226 T1 ATE404226 T1 AT E404226T1
- Authority
- AT
- Austria
- Prior art keywords
- solid particles
- immobilized
- brachytherapy
- composition containing
- containing radioisotopes
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 239000002245 particle Substances 0.000 title abstract 3
- 239000007787 solid Substances 0.000 title abstract 3
- 238000002725 brachytherapy Methods 0.000 title 1
- 230000001613 neoplastic effect Effects 0.000 abstract 2
- 230000002285 radioactive effect Effects 0.000 abstract 2
- 238000001356 surgical procedure Methods 0.000 abstract 2
- 229920001817 Agar Polymers 0.000 abstract 1
- 229920000936 Agarose Polymers 0.000 abstract 1
- 241000206672 Gelidium Species 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 235000010419 agar Nutrition 0.000 abstract 1
- 239000000470 constituent Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000000499 gel Substances 0.000 abstract 1
- 239000011159 matrix material Substances 0.000 abstract 1
- 229940121896 radiopharmaceutical Drugs 0.000 abstract 1
- 239000012217 radiopharmaceutical Substances 0.000 abstract 1
- 230000002799 radiopharmaceutical effect Effects 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/1213—Semi-solid forms, gels, hydrogels, ointments, fats and waxes that are solid at room temperature
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
- A61K51/1244—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins microparticles or nanoparticles, e.g. polymeric nanoparticles
- A61K51/1251—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins microparticles or nanoparticles, e.g. polymeric nanoparticles micro- or nanospheres, micro- or nanobeads, micro- or nanocapsules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Optics & Photonics (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Dispersion Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nanotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT98RM000303A IT1299175B1 (it) | 1998-05-11 | 1998-05-11 | Composizione contenente radioisotopi immobilizzati su particelle solide, utile in particolare per la brachiterapia clinica in patologie |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE404226T1 true ATE404226T1 (de) | 2008-08-15 |
Family
ID=11405917
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98830776T ATE404226T1 (de) | 1998-05-11 | 1998-12-23 | Zusammensetzung enthaltend auf festen teilchen immobilisierte radioisotopen, sowie deren verwendung in der brachytherapie |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP0979656B1 (de) |
| AT (1) | ATE404226T1 (de) |
| DE (1) | DE69839875D1 (de) |
| IT (1) | IT1299175B1 (de) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007008232A2 (en) | 2004-09-03 | 2007-01-18 | Board Of Regents, The University Of Texas System | Locoregional internal radionuclide ablation of abnormal tissues. |
| US20090304587A1 (en) * | 2005-11-01 | 2009-12-10 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Biodegradable composite for internal local radiotherapy |
| US9855445B2 (en) | 2016-04-01 | 2018-01-02 | Varian Medical Systems, Inc. | Radiation therapy systems and methods for delivering doses to a target volume |
| US11590364B2 (en) | 2017-07-21 | 2023-02-28 | Varian Medical Systems International Ag | Material inserts for radiation therapy |
| US11712579B2 (en) | 2017-07-21 | 2023-08-01 | Varian Medical Systems, Inc. | Range compensators for radiation therapy |
| EP3654976A1 (de) | 2017-07-21 | 2020-05-27 | Varian Medical Systems, Inc. | Verfahren zur verwendung von ultrahochdosierter strahlung und therapeutika |
| US10843011B2 (en) | 2017-07-21 | 2020-11-24 | Varian Medical Systems, Inc. | Particle beam gun control systems and methods |
| US10549117B2 (en) | 2017-07-21 | 2020-02-04 | Varian Medical Systems, Inc | Geometric aspects of radiation therapy planning and treatment |
| US10183179B1 (en) | 2017-07-21 | 2019-01-22 | Varian Medical Systems, Inc. | Triggered treatment systems and methods |
| US10092774B1 (en) | 2017-07-21 | 2018-10-09 | Varian Medical Systems International, AG | Dose aspects of radiation therapy planning and treatment |
| EP3710111B1 (de) | 2017-11-16 | 2021-12-29 | Varian Medical Systems, Inc. | Erhöhte strahlausgabe und dynamische feldformung für strahlentherapiesystem |
| US10910188B2 (en) | 2018-07-25 | 2021-02-02 | Varian Medical Systems, Inc. | Radiation anode target systems and methods |
| US11116995B2 (en) | 2019-03-06 | 2021-09-14 | Varian Medical Systems, Inc. | Radiation treatment planning based on dose rate |
| US10814144B2 (en) | 2019-03-06 | 2020-10-27 | Varian Medical Systems, Inc. | Radiation treatment based on dose rate |
| US11103727B2 (en) | 2019-03-08 | 2021-08-31 | Varian Medical Systems International Ag | Model based PBS optimization for flash therapy treatment planning and oncology information system |
| US11090508B2 (en) | 2019-03-08 | 2021-08-17 | Varian Medical Systems Particle Therapy Gmbh & Co. Kg | System and method for biological treatment planning and decision support |
| US10918886B2 (en) | 2019-06-10 | 2021-02-16 | Varian Medical Systems, Inc. | Flash therapy treatment planning and oncology information system having dose rate prescription and dose rate mapping |
| US11291859B2 (en) | 2019-10-03 | 2022-04-05 | Varian Medical Systems, Inc. | Radiation treatment planning for delivering high dose rates to spots in a target |
| US12390662B2 (en) | 2020-04-02 | 2025-08-19 | Siemens Healthineers International Ag | System and method for proton therapy treatment planning with proton energy and spot optimization |
| US11865361B2 (en) | 2020-04-03 | 2024-01-09 | Varian Medical Systems, Inc. | System and method for scanning pattern optimization for flash therapy treatment planning |
| US11541252B2 (en) | 2020-06-23 | 2023-01-03 | Varian Medical Systems, Inc. | Defining dose rate for pencil beam scanning |
| US11957934B2 (en) | 2020-07-01 | 2024-04-16 | Siemens Healthineers International Ag | Methods and systems using modeling of crystalline materials for spot placement for radiation therapy |
| US12064645B2 (en) | 2020-07-02 | 2024-08-20 | Siemens Healthineers International Ag | Methods and systems used for planning radiation treatment |
| AU2021414121A1 (en) * | 2020-12-29 | 2023-06-29 | Suzhou Xinxin Biopharma Co., Ltd | Compositions and associated methods for sustained-release of radioactive agents and their applications |
| CN116672498B (zh) * | 2022-02-23 | 2025-07-01 | 济南格莱威医疗科技有限公司 | 一种注射用复合材料及其用途 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE444989B (sv) * | 1979-12-17 | 1986-05-20 | Jan Ivan Thorell | Reagenskomposition for radioimmunologiska bestemningsmetoder |
| US5061475A (en) * | 1985-06-07 | 1991-10-29 | Cadema Medical Products, Inc. | Composition and method of treatment of arthritis and related diseases with holmium-166 radionuclides |
| EP0438527A4 (en) * | 1988-10-14 | 1992-07-01 | Mallinckrodt, Inc. | Radiolabelled particulate composition |
| JPH06218276A (ja) * | 1993-01-27 | 1994-08-09 | Mitsui Toatsu Chem Inc | 安定化された金属酸化物超微粒子とその製造方法 |
| EP0921756A4 (de) * | 1996-06-24 | 2003-05-21 | Du Pont Merck Pharma | Radiopharmazeutische verbindungen und matrizen sowie deren anwendung |
-
1998
- 1998-05-11 IT IT98RM000303A patent/IT1299175B1/it active IP Right Grant
- 1998-12-23 AT AT98830776T patent/ATE404226T1/de not_active IP Right Cessation
- 1998-12-23 EP EP98830776A patent/EP0979656B1/de not_active Expired - Lifetime
- 1998-12-23 DE DE69839875T patent/DE69839875D1/de not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ITRM980303A1 (it) | 1999-11-11 |
| EP0979656B1 (de) | 2008-08-13 |
| EP0979656A2 (de) | 2000-02-16 |
| ITRM980303A0 (it) | 1998-05-11 |
| DE69839875D1 (de) | 2008-09-25 |
| IT1299175B1 (it) | 2000-02-29 |
| EP0979656A3 (de) | 2004-03-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69839875D1 (de) | Zusammensetzung enthaltend auf festen Teilchen immobilisierte Radioisotopen, sowie deren Verwendung in der Brachytherapie | |
| MY121548A (en) | Compounds and methods for the treatment of cancer | |
| BR9915080A (pt) | Fonte radioativa para uso em braquiterapia, métodos para a preparação de uma fonte radioativa e para tratamento de uma condição que responde à terapia de radiação, e, composição | |
| Barker et al. | BCNU and X-ray therapy of intracerebral 9L rat tumors | |
| DE69830072D1 (de) | Radioaktive zusammensetzungen zur behandlung von prostatatumoren | |
| DE69711894D1 (de) | Lipoxinverbindungen und deren verwendung zur behandlung der zellenwucherungsstörung | |
| DK96588A (da) | Antitumirmiddel indeholdende makromolekylaere platinforbindelser | |
| ATE277515T1 (de) | Verfahren zur behandlung von pigmentierten krebszellen durch photodynamische therapie | |
| FI972086A7 (fi) | Parannetun monilääkeresistenssiaktiivisuuden omaavat uudet aminohappoj ohdokset | |
| WO1995031559A3 (en) | Methods of inducing gene expression by ionizing radiation | |
| DE3376295D1 (en) | Pharmaceutical composition containing adenosine derivatives for use in treating tumours | |
| AR012626A1 (es) | Una composicion farmaeutica que comprende un derivado o análogo de leptina como inhibidor de la proliferacion de células de tumor y el uso de dicha composicion farmaceutica para la manufactura de medicamento para el tratamiento de tumores | |
| AU7655300A (en) | Radiation source for endovascular radiation treatment in form of a wire | |
| ATE67094T1 (de) | Knochenzement. | |
| DK0951553T3 (da) | Adenovirus-E4-proteiner til induktion af celledød | |
| DK0730871T3 (da) | Radioaktivt kompleks og anvendelsen heraf til strålebehandling | |
| DK0768886T3 (da) | Endothelforingseffekter og behandling af vasospastiske lidelser | |
| ES2110057T3 (es) | Composicion medicinal que contiene tcf-ii. | |
| DK0697875T3 (da) | Anvendelse af modificerede TALL-104 celler til behandling af cancer og virale sygdomme | |
| ATE512664T1 (de) | Sphingomyelin enthaltende zusammensetzung zur behandlung der rheumatoiden arthritis | |
| EP1351967A4 (de) | Zusammensetzungen und verfahren zur therapie und diagnose von lungenkrebs | |
| DK484685A (da) | Micellulaere partikelkompositioner til maalrettet tilfoersel til tumorer i mennesker og kompositionernes anvendelse | |
| CA2320138A1 (en) | Therapeutic instrument for treating or relieving psoriasis, atopic dermatitis, articular rheumatism and/or cancer or preventing the progress of these diseases and method of utilization thereof | |
| ZA885625B (en) | Therapeutic agents containing enantiomers of propafenone | |
| SCHULZ-WENDTLAND | Effect of Dose per Pulse, Pulse Duration, and Total----Exposure Time of Pulsed Dose Rate Brachytherapy: Results ofan In Vitro Model |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |